Position in ROIV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,075,438
+$6,008,486 QoQ
Shares Held
255,431
+262.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $285,821,171 across 374 Biotechnology names. ROIV ranks #1 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
255,431 | $7,075,438 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,632 | $6,980,313 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
80,519 | $6,046,171 | |
| 4 | EXEL |
Exelixis, Inc.
|
134,413 | $5,764,973 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,354 | $5,466,117 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
160,880 | $5,442,570 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
93,609 | $5,287,972 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
59,502 | $5,174,888 |
All Filings in ROIV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,075,438 | 255,431 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $1,066,952 | 70,519 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $2,590,244 | 256,714 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $413,718 | 34,972 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $640,470 | 55,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $271,205 | 25,658 | Shares | Defined | 2024-08-12 | |
| 2023-06-30 | $117,653 | 11,672 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $161,437 | 20,205 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||